Key result
The subcutaneous implantable cardioverter-defibrillator can reduce the negative psychosocial impact of device implantation by avoiding aesthetic concerns and activity limitations.
Why the study?
The subcutaneous implantable cardioverter-defibrillator is a new technology, but the patient perspective regarding its biopsychosocial impact compared to transvenous ICDs needed exploration.
Does the subcutaneous implantable cardioverter-defibrillator (S-ICD) improve patient well-being and reduce lifestyle limitations compared to transvenous ICDs?
Does the subcutaneous implantable cardioverter-defibrillator (S-ICD) improve patient well-being and reduce lifestyle limitations compared to transvenous ICDs?
Answers are grounded in this paper and cite their sources.
The S-ICD offers potential psychosocial and lifestyle benefits over transvenous ICDs for specific patient groups, such as younger women and athletes, by avoiding vascular complications and reducing aesthetic concerns.
The subcutaneous implantable cardioverter-defibrillator (S-ICD) is a new technology for the management of ICD patients. But what is the patients' perspective? Previous studies on the transvenous ICD (TV-ICD) showed that device implantation is related not only to anxiety and depression because of the fear of ICD shocks, but also to many biopsychosocial factors like body image changes, perceived reduction of socialization and limitation in professional and sports activities. Anxiety and distress are more evident in younger women because of aesthetic reasons. The scar size and the position of the S-ICD can help these patients and positively influence their social relationships. Moreover, the position of the S-ICD reduces possible complications from catheters due to stress injury and can improve patients' professional life by avoiding some work activity limitations. An S-ICD can be also a good option for athletes in avoiding subclavian crash and reducing inappropriate shocks. However, some questions remain unsolved because an S-ICD is not suitable for patients with indications for pacing, cardiac resynchronization therapy or anti-tachycardia pacing. In conclusion, the use of an S-ICD can assist physicians in reducing the negative impact of implantation on the well-being of some groups of patients by helping them to avoid depression and anxiety as well as improving their noncompliance with their medical treatment.
No takes yet. Share an insight, caveat, or question.
Nesti et al. (2023) conducted a review in Patients requiring an implantable cardioverter-defibrillator. Subcutaneous implantable cardioverter-defibrillator (S-ICD) vs. Transvenous ICD (TV-ICD) was evaluated. The subcutaneous implantable cardioverter-defibrillator can reduce the negative psychosocial impact of device implantation by avoiding aesthetic concerns and activity limitations.
Synapse has enriched 10 related papers. Consider them for comparative context: